Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Invested Capital (2019 - 2022)

Regenxbio has reported Return on Invested Capital over the past 4 years, most recently at 0.0% for Q4 2022.

  • For Q4 2022, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2022 reached 0.0%, changed 0.0%, while the annual FY2023 figure was 0.01%, 1.0% down from the prior year.
  • Return on Invested Capital for Q4 2022 was 0.0% at Regenxbio, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.16% in Q4 2019 and troughed at 0.17% in Q4 2020.
  • A 4-year average of 0.0% and a median of 0.0% in 2021 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: crashed -33bps in 2020 and later increased 18bps in 2021.
  • Year by year, Return on Invested Capital stood at 0.16% in 2019, then plummeted by -211bps to 0.17% in 2020, then skyrocketed by 101bps to 0.0% in 2021, then crashed by -36bps to 0.0% in 2022.
  • Business Quant data shows Return on Invested Capital for RGNX at 0.0% in Q4 2022, 0.0% in Q3 2022, and 0.0% in Q2 2022.